2012-09-17 06:03:19 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Dysmenorrhea - Pipeline Review, H2 2012', provides an overview of the Dysmenorrhea therapeutic pipeline. This report provides information on the therapeutic development for Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dysmenorrhea. 'Dysmenorrhea - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot

of the global therapeutic scenario for Dysmenorrhea.
* A review of the Dysmenorrhea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Dysmenorrhea pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/463722_dysmenorrhea_pipeline_review_h2_2012. ..


Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Dysmenorrhea.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Dysmenorrhea pipeline depth and focus of Dysmenorrhea therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Dysmenorrhea Therapeutic Products under Development, Key Players in Dysmenorrhea Therapeutics, Dysmenorrhea Pipeline Overview, Dysmenorrhea Pipeline, Dysmenorrhea Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Dysmenorrhea Overview
Therapeutics Development
An Overview of Pipeline Products for Dysmenorrhea
Dysmenorrhea Therapeutics under Development by Companies
Dysmenorrhea Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Dysmenorrhea Therapeutics - Products under Development by Companies
Dysmenorrhea Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Dysmenorrhea Therapeutics Development
Columbia Laboratories Inc.
China Aoxing Pharmaceutical Co., Inc
PDC Biotech GmbH
Nobelpharma Co., Ltd.
Vantia Therapeutics
Dysmenorrhea - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Peptidometics - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PDC41 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PDC31 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lidocaine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VA111913 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Viagra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Gestodene + Ethinyl Estradiol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Fenellin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tongjingshule - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NPC-01 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Mefenamic Acid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Colpermin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zinc - Drug Profile
Product Description
Mechanism of Action

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463722&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.